Michelle L. O’Donoghue

Statistics

Publications

Citations

9.5K

H-Index

Active since

2005

Affiliations

Thrombolysis in Myocardial Infarction Study Group(Current)

Brigham and Women's Hospital

Harvard University

Massachusetts General Hospital

Amgen (United States)

Michelle L. O’Donoghue is an author at Thrombolysis in Myocardial Infarction Study Group specializing in medicine, cardiology, and clinical pharmacology.

ORCID

Publications per year

2005–2025

Publications

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Michelle L. O’Donoghue, Sergio Fazio, Robert P. Giugliano et al. · Circulation · 2019 · 948 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger et al. · Circulation · 2007 · 877 citations

Medicine, Pharmacology, Pharmacotherapy +17

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

Michelle L. O’Donoghue, Robert S. Rosenson, Bariş Gencer et al. · New England Journal of Medicine · 2022 · 521 citations · Full text

Life Sciences, Cardiology, Molecular Biology +14

Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea

James L. Januzzi, W. Frank Peacock, Alan S. Maisel et al. · Journal of the American College of Cardiology · 2007 · 515 citations

Medicine, Immunology, Internal Medicine +13

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White et al. · JAMA · 2014 · 456 citations

Medicine, Cardiology, Pharmacology +17

1–5 of 82